Literature DB >> 10733450

Palliative treatments of last resort: choosing the least harmful alternative. University of Pennsylvania Center for Bioethics Assisted Suicide Consensus Panel.

T E Quill1, B C Lee, S Nunn.   

Abstract

Comprehensive palliative care, as exemplified by many state-of-the-art hospice programs, is the standard of care for the dying. Although palliative care is very effective, physicians, nurses, patients, families, and loved ones regularly face clinically, ethically, legally, and morally challenging decisions throughout the dying process. This is especially true when terminally ill patients are ready to die in the face of complex, difficult-to-treat suffering and request assistance from their health care providers. Although physician-assisted suicide has received the most attention as a potential last-resort response, this practice remains illegal in the United States except in Oregon, and even there it is relatively infrequent. More commonly, decisions are made about accelerating opioid therapy for pain, foregoing life-sustaining therapy, voluntarily stopping eating and drinking, and administering terminal sedation in response to unacceptable suffering. The moral distinctions between these practices are critical to some but relatively inconsequential to others. This paper illustrates, through summaries of real clinical cases, how each of these practices might be used in response to patients in particular clinical circumstances, keeping in focus the patient's values as well as those of families, other loved ones, and health care providers. The challenge is to find the least harmful solution to the patient's problem without abandoning patients and their loved ones to unacceptable suffering or to acting in a more deleterious way on their own.

Entities:  

Keywords:  Death and Euthanasia

Mesh:

Substances:

Year:  2000        PMID: 10733450     DOI: 10.7326/0003-4819-132-6-200003210-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  [The end of the last disease].

Authors:  Jaime Sanz Ortiz
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

Review 2.  Euthanasia, efficiency, and the historical distinction between killing a patient and allowing a patient to die.

Authors:  J P Bishop
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

3.  Addressing the Concerns Surrounding Continuous Deep Sedation in Singapore and Southeast Asia: A Palliative Care Approach.

Authors:  Lalit Kumar Radha Krishna
Journal:  J Bioeth Inq       Date:  2015-07-15       Impact factor: 1.352

4.  A cross-cultural study of physician treatment decisions for demented nursing home patients who develop pneumonia.

Authors:  Margaret R Helton; Jenny T van der Steen; Timothy P Daaleman; George R Gamble; Miel W Ribbe
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

5.  The last low whispers of our dead: when is it ethically justifiable to render a patient unconscious until death?

Authors:  Daniel P Sulmasy
Journal:  Theor Med Bioeth       Date:  2018-06

Review 6.  [Limits of pain treatment: medical and judicial aspects].

Authors:  M Zenz; R Rissing-van Saan
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

7.  Considerations about hastening death among parents of children who die of cancer.

Authors:  Veronica Dussel; Steven Joffe; Joanne M Hilden; Jan Watterson-Schaeffer; Jane C Weeks; Joanne Wolfe
Journal:  Arch Pediatr Adolesc Med       Date:  2010-03

8.  The agony of agonal respiration: is the last gasp necessary?

Authors:  R M Perkin; D B Resnik
Journal:  J Med Ethics       Date:  2002-06       Impact factor: 2.903

9.  Continuous deep sedation for patients nearing death in the Netherlands: descriptive study.

Authors:  Judith Rietjens; Johannes van Delden; Bregje Onwuteaka-Philipsen; Hilde Buiting; Paul van der Maas; Agnes van der Heide
Journal:  BMJ       Date:  2008-03-14

10.  Internists' attitudes towards terminal sedation in end of life care.

Authors:  L C Kaldjian; J F Jekel; J L Bernene; G E Rosenthal; M Vaughan-Sarrazin; T P Duffy
Journal:  J Med Ethics       Date:  2004-10       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.